Log In
Print this Print this

EB66 pandemic influenza vaccine

  Manage Alerts
Collapse Summary General Information
Company Valneva SE
DescriptionPandemic influenza vaccine adjuvanted with GSK's proprietary adjuvant system, AS03
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase III
Standard IndicationInfluenza virus
Indication DetailsPrevent influenza
Regulatory Designation
PartnerGlaxoSmithKline plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today